The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
973
April 26, 1996
View Complete Issue         Table of Contents 2019 
Methotrexate and Misoprostol for Abortion
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Methotrexate and Misoprostol for Abortion
April 26, 1996 (Issue: 973)
Recent articles in the press have suggested that in early pregnancy, an intramuscular (IM) injection of methotrexate (Folex, and others), a folic acid antagonist, and oral or vaginal administration of misoprostol (Cytotec), a prostaglandin, offers...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Methotrexate and Misoprostol for Abortion
Article code: 973a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.